Used in pharmaceutical research as a potent and selective antagonist of the A2B adenosine receptor. It shows promise in the development of treatments for inflammatory diseases, asthma, and certain types of cancer due to its ability to modulate immune responses and inhibit tumor growth in preclinical models. Its structure allows for high receptor binding affinity and improved metabolic stability, making it a valuable scaffold in drug design. Also employed in studies exploring cardiovascular protection and ischemia-reperfusion injury.